Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Conflicting evidence on the frequency of ESR1 amplification in breast cancer.

Albertson DG.

Nat Genet. 2008 Jul;40(7):821-2. doi: 10.1038/ng0708-821. No abstract available.

PMID:
18583976
2.

ESR1 gene amplification in breast cancer: a common phenomenon?

Reis-Filho JS, Drury S, Lambros MB, Marchio C, Johnson N, Natrajan R, Salter J, Levey P, Fletcher O, Peto J, Ashworth A, Dowsett M.

Nat Genet. 2008 Jul;40(7):809-10; author reply 810-2. doi: 10.1038/ng0708-809b. No abstract available.

PMID:
18583966
3.

ESR1 gene amplification in breast cancer: a common phenomenon?

Horlings HM, Bergamaschi A, Nordgard SH, Kim YH, Han W, Noh DY, Salari K, Joosse SA, Reyal F, Lingjaerde OC, Kristensen VN, Børresen-Dale AL, Pollack J, van de Vijver MJ.

Nat Genet. 2008 Jul;40(7):807-8; author reply 810-2. doi: 10.1038/ng0708-807. No abstract available.

PMID:
18583965
4.

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, Sauter G, Simon R.

Nat Genet. 2007 May;39(5):655-60. Epub 2007 Apr 8.

PMID:
17417639
5.

Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.

Tomita S, Zhang Z, Nakano M, Ibusuki M, Kawazoe T, Yamamoto Y, Iwase H.

Cancer Sci. 2009 Jun;100(6):1012-7. doi: 10.1111/j.1349-7006.2009.01145.x. Epub 2009 Feb 25.

6.

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

Tan DS, Lambros MB, Marchiò C, Reis-Filho JS.

J Pathol. 2008 Nov;216(3):271-4. doi: 10.1002/path.2432.

PMID:
18788074
7.

ESR1 gene amplification in breast cancer: a common phenomenon?

Vincent-Salomon A, Raynal V, Lucchesi C, Gruel N, Delattre O.

Nat Genet. 2008 Jul;40(7):809; author reply 810-2. doi: 10.1038/ng0708-809a. No abstract available.

PMID:
18583967
8.

Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study.

Ooi A, Inokuchi M, Harada S, Inazawa J, Tajiri R, Kitamura SS, Ikeda H, Kawashima H, Dobashi Y.

J Pathol. 2012 May;227(1):8-16. doi: 10.1002/path.3974. Epub 2012 Feb 2.

PMID:
22170254
9.

ESR1 amplification in breast cancer: controversy resolved?

Albertson DG.

J Pathol. 2012 May;227(1):1-3. doi: 10.1002/path.3999. Epub 2012 Mar 19.

PMID:
22322671
10.

ESR1 gene amplification in breast cancer: a common phenomenon?

Brown LA, Hoog J, Chin SF, Tao Y, Zayed AA, Chin K, Teschendorff AE, Quackenbush JF, Marioni JC, Leung S, Perou CM, Neilsen TO, Ellis M, Gray JW, Bernard PS, Huntsman DG, Caldas C.

Nat Genet. 2008 Jul;40(7):806-7; author reply 810-2. doi: 10.1038/ng0708-806. No abstract available.

11.

Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.

Lebeau A, Grob T, Holst F, Seyedi-Fazlollahi N, Moch H, Terracciano L, Turzynski A, Choschzick M, Sauter G, Simon R.

J Pathol. 2008 Oct;216(2):151-7. doi: 10.1002/path.2405.

PMID:
18720455
12.

ESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.

Moelans CB, Holst F, Hellwinkel O, Simon R, van Diest PJ.

PLoS One. 2013 Dec 18;8(12):e84189. doi: 10.1371/journal.pone.0084189. eCollection 2013.

13.

Estrogen receptor gene amplification occurs rarely in ovarian cancer.

Issa RM, Lebeau A, Grob T, Holst F, Moch H, Terracciano L, Choschzick M, Sauter G, Simon R.

Mod Pathol. 2009 Feb;22(2):191-6. doi: 10.1038/modpathol.2008.130. Epub 2008 Aug 8.

14.

Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.

Tsezou A, Tzetis M, Gennatas C, Giannatou E, Pampanos A, Malamis G, Kanavakis E, Kitsiou S.

Breast. 2008 Apr;17(2):159-66. Epub 2007 Sep 29.

PMID:
17904846
15.

Status of estrogen receptor 1 (ESR1) gene in mastopathy predicts subsequent development of breast cancer.

Soysal SD, Kilic IB, Regenbrecht CR, Schneider S, Muenst S, Kilic N, Güth U, Dietel M, Terracciano LM, Kilic E.

Breast Cancer Res Treat. 2015 Jun;151(3):709-15. doi: 10.1007/s10549-015-3427-y. Epub 2015 May 16.

PMID:
25981900
17.

Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis.

Li N, Dong J, Hu Z, Shen H, Dai M.

Breast Cancer Res Treat. 2010 May;121(1):177-84. doi: 10.1007/s10549-009-0532-9. Epub 2009 Sep 17.

PMID:
19760036
18.

Diverse associations between ESR1 polymorphism and breast cancer development and progression.

Ding SL, Yu JC, Chen ST, Hsu GC, Hsu HM, Ho JY, Lin YH, Chang CC, Fann CS, Cheng CW, Wu PE, Shen CY.

Clin Cancer Res. 2010 Jul 1;16(13):3473-84. doi: 10.1158/1078-0432.CCR-09-3092. Epub 2010 Jun 22.

19.

Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.

Conway K, Parrish E, Edmiston SN, Tolbert D, Tse CK, Moorman P, Newman B, Millikan RC.

Breast Cancer Res. 2007;9(3):R36.

20.

[The analysis of estrogen receptor alpha (ER-alpha) gene Pvull and Xbal polymorphisms in postmenopausal women with breast cancer].

Sobczuk A, Pertyński T, Smolarz B, Romanowicz-Makowska H.

Pol Merkur Lekarski. 2008 Jul;25(145):43-5. Polish.

PMID:
18839613
Items per page

Supplemental Content

Write to the Help Desk